A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

Saved in:

Bibliographic Details
Published in:	Cancer Immunology, Immunotherapy Vol. 68; no. 4; pp. 619 - 629
Main Authors:	Suarez-Kelly, Lorena P., Levine, Kala M., Olencki, Thomas E., del Campo, Sara E. Martin, Streacker, Elizabeth A., Brooks, Taylor R., Karpa, Volodymyr I., Markowitz, Joseph, Bingman, Anissa K., Geyer, Susan M., Kendra, Kari L., Carson, William E.
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01-04-2019 Springer Nature B.V
Subjects:	Adjuvant therapy Adjuvants, Pharmaceutic - administration & dosage Adult Aged Cancer Research Cells, Cultured Clinical Trial Report Drug Dosage Calculations Female Humans Immunology Interferon alpha-2 Interferon Regulatory Factors - genetics Interferon-alpha - administration & dosage Janus Kinases - metabolism Leukocytes, Mononuclear - physiology Male Medicine Medicine & Public Health Melanoma Melanoma - drug therapy Middle Aged Oncology Pilot Projects Prospective Studies Signal Transduction Skin Neoplasms - drug therapy STAT Transcription Factors - metabolism Young Adult α-Interferon
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0340-7004 1432-0851
DOI:	10.1007/s00262-019-02308-w